Search
Advance downstream purification with membrane chromatography
Downstream purification teams face increasing pressure to improve throughput, reduce process steps, and manage complex impurity profiles. Traditional column chromatography remains central to purification strategies, yet evolving process demands require teams to consider complementary approaches that address specific bottlenecks. Membrane chromatography has emerged as one option that process scientists and engineers evaluate when looking to simplify or intensify targeted downstream steps. Its adsorptive format and convective-flow characteristics position it as an alternative for select unit operations within the purification train.
How membrane chromatography works
Membrane chromatography operates through adsorptive interactions between target molecules or impurities and functional ligands immobilized on a porous membrane structure. Unlike column-based chromatography, where mass transfer relies heavily on diffusion through resin beads, membrane formats use convective flow through interconnected pore networks. This convection-driven mechanism can reduce residence time requirements and support high volumetric flow rates. Chromatography membranes are typically configured as layered or stacked formats within a capsule housing. Anion exchange (AEX) functionality is commonly used, though membrane formats can accommodate a range of ligand chemistries depending on application requirements.
Where membrane chromatography fits in antibody and biologics purification
Membrane chromatography is applied at distinct unit operations across downstream workflows. Its applicability varies by modality, process design, and the specific purification challenge being addressed, often in capture or polishing roles. A clear definition of the unit operation's objective is important for effective implementation.
Membrane chromatography for polishing antibodies and biologics
In monoclonal antibody workflows, membrane chromatography is commonly applied for polishing applications in purification following protein A capture in antibody purification workflows. In flow-through mode, the therapeutic antibody passes through the membrane while host cell proteins (HCP), DNA, leached protein A, and viruses are retained or adsorbed, supporting impurity reduction without binding the target molecule. This approach can maintain throughput while addressing the polishing objectives typically assigned to a post-capture AEX step.
Where membrane chromatography fits in AAV purification
Membrane chromatography is assessed for both capture and downstream impurity reduction applications in gene therapy workflows. Process design considerations, including vector type and upstream harvest characteristics, affect how and where membrane steps are incorporated.
Membrane chromatography for AAV capture applications
In some downstream workflows, membrane chromatography is used for capture applications where specific target properties and process design objectives make membrane formats a viable starting point. AAV gene therapy is an area where membrane-based capture is actively implemented, given the physicochemical characteristics of AAV vectors and the impurity profiles typical of upstream cell culture harvests. Teams designing AAV purification processes may consider membrane capture based on factors such as particle size, required binding capacity, and early-step impurity reduction requirements.
Why teams consider membrane chromatography
When reassessing or modernizing downstream purification strategies, process development teams often evaluate membrane chromatography based on practical workflow considerations. The decision to incorporate a membrane step is typically driven by specific operational objectives, such as single-use compatibility, throughput targets, or a defined point in the purification train.
Membrane chromatography across biologics modalities
Membrane chromatography is evaluated across a range of biologics modalities, including monoclonal antibodies (mAbs) and gene therapy vectors. Application and implementation vary by molecule type, workflow design, and stage of development.
Discover membrane chromatography solutions
Thermo Fisher Scientific supports downstream purification workflows with a portfolio of membrane chromatography solutions designed to address unit operations across biologics modalities. Whether teams are evaluating membrane formats for early-step capture or post-capture polishing, these solutions are built to integrate with existing downstream strategies, including resins and filtration, rather than replace established chromatography platforms.
These solutions, such as GoPure AAVX Affinity Membrane and Polisher ST Membrane Adsorber, give purification teams the flexibility to incorporate membrane steps at defined points in the process train.
Ordering information
Related resources
Frequently asked questions
Membrane chromatography is typically considered alongside resin-based approaches when a specific downstream step imposes throughput constraints, offers step-reduction opportunities, or requires single-use compatibility. Teams evaluate membranes as a complementary option at defined unit operations, particularly capture or polish steps.
Downstream purification challenges that lead to the evaluation of membrane chromatography include throughput limitations at polishing steps, process complexities, and operational considerations; these may include cleaning validation requirements and changeover time. Teams also assess membranes when process simplification or alignment with single-use manufacturing strategies is a stated development objective.
Membrane chromatography functions differently in the capture and polishing steps, and the two use cases are treated separately. In capture applications, such as gene therapy workflows, membranes may bind the target molecule early in downstream processing. In polishing applications, membranes typically operate in flow-through mode to reduce HCP, DNA, leached protein A, and viral impurities post-capture.
Membrane chromatography is established in monoclonal antibody polishing workflows, where flowthrough AEX applications are well characterized. In gene therapy, membrane-based capture and impurity reduction applications are actively evaluated, though adoption varies by vector type and program stage.
Single-use membrane formats are designed to support consistency from process development through manufacturing, offering a fixed-format capsule that eliminates column packing and cleaning validation requirements. Scalable configurations from small laboratory units to large-scale capsules can facilitate technology transfer by maintaining comparable operating conditions across scales.
Bioprocessing products & resources
We support downstream purification as part of a broader portfolio of bioprocessing products that spans upstream and downstream workflow needs. Teams designing integrated bioprocessing strategies can explore adjacent product families, including chromatography resins and bioprocess filtration.
_11zon.jpg "Two people in lab coats smiling in a lab setting")
Additional bioprocessing resources
Bioprocessing resources
Intended use of the products mentioned on this page vary. For specific intended use statements, please refer to the Instructions for Use for the product.